Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Effect van evobrutinib op ‘slowly expanding lesion’-volume bij relapsing MS
apr 2024 | Multipele Sclerose